The slip
PARKINSON RECEIPTno. 14612
30 Oct 2026, 00:29 UTCdopamine neurons, braak
predictionTAOK2 in dopamine neurons tracks Braak Lewy-body stage
registered4a6baa00665305e4
discovery-0.62 p=0.073 n=9
replication-0.38 p=0.311 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.62, p 0.073)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT4c49ca308ad11c64ff37f0fe…
follows bb35961c6cb5…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 14612: TAOK2 in dopamine neurons, braak
- power
- full sample -0.48 (p 0.045, n 18), 95% CI -0.77 to -0.01. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.59 (p 0.0099, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.66 (p 0.0030, n 18). not the mix.
- skeptic
- leave-one-out range -0.61 to -0.39, sign flips 0; without severely affected donors -0.48 (p 0.045, n 18). robust.
- cell type
- strongest in astrocytes: -0.59 (p 0.0096, n 18) vs -0.48 in dopamine neurons. proposing astrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for TAOK2 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up TAOK2 · astrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.48 p 0.091 (needs p < 1.6e-4)